Also, anti-β2GPI IgG, which is otherwise connected with thrombosis, tested newly positive in 14.9% and 20.8% of aPLs-positive patients at discharge and was confirmed at a 3-month follow-up, but these patients were not followed further for thrombosis in their lifetime. This evidence concerns the gene APOH and deep vein thrombosis.